|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
726527 |
| 003 |
ICU |
| 005 |
20030518004800.0 |
| 008 |
851210s1985 ne a b 100 0 eng d |
| 020 |
|
|
|a 4900392545 (pbk.)
|
| 020 |
|
|
|a 0444807004 (Elsevier)
|
| 035 |
|
|
|a (ICU)BID9359167
|
| 035 |
|
|
|a (OCoLC)15521657
|
| 040 |
|
|
|a NLM
|c NLM
|d UCH
|d PPC
|d MDU
|d ICU
|d OCoLC
|
| 041 |
0 |
|
|a eng
|
| 060 |
|
|
|a W3
|b EX89 no.690 1985
|a [QZ 267 S9899 1984r]
|
| 090 |
|
|
|a RC271.A35S9 1985
|
| 111 |
2 |
|
|a Symposium on Rationale of Biological Response Modifiers in Cancer Treatment
|n (6th :
|d 1984 :
|c Hakone-machi, Japan)
|1 http://viaf.org/viaf/154262397
|
| 245 |
1 |
0 |
|a Rationale of biological response modifiers in cancer treatment :
|b proceedings of the Sixth Symposium on Rationale of Biological Response Modifiers in Cancer Treatment, Hakone, Japan, August 31-September 1, 1984 /
|c organizing committee, Eiro Tsubura, Ichiro Urushizaki, Tadao Aoki ; secretariat, Saburo Sone, Yutaro Kaneko.
|
| 260 |
|
|
|a Amsterdam ; Princeton :
|b Excerpta Medica,
|c 1985.
|
| 300 |
|
|
|a 267 p. :
|b ill.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 440 |
|
0 |
|a International congress series
|v no. 690
|
| 504 |
|
|
|a Includes bibliographies.
|
| 650 |
|
2 |
|a Adjuvants, Immunologic
|x therapeutic use
|v Congresses.
|
| 650 |
|
2 |
|a Antineoplastic Agents
|x therapeutic use
|v congresses.
|
| 650 |
|
2 |
|a Neoplasms
|x drug therapy
|v congresses.
|
| 650 |
|
2 |
|a Neoplasms
|x immunology
|v congresses.
|
| 650 |
|
0 |
|a Immunological adjuvants
|x Therapeutic use
|v Congresses.
|
| 650 |
|
0 |
|a Antineoplastic agents
|v Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2008117595
|
| 650 |
|
0 |
|a Cancer
|x Adjuvant treatment
|v Congresses.
|0 http://id.loc.gov/authorities/subjects/sh2008005053
|
| 650 |
|
7 |
|a Antineoplastic agents.
|2 fast
|0 http://id.worldcat.org/fast/fst00810595
|
| 650 |
|
7 |
|a Cancer
|x Adjuvant treatment.
|2 fast
|0 http://id.worldcat.org/fast/fst00845318
|
| 650 |
|
7 |
|a Immunological adjuvants
|x Therapeutic use.
|2 fast
|0 http://id.worldcat.org/fast/fst00967993
|
| 655 |
|
7 |
|a Conference papers and proceedings.
|2 fast
|0 http://id.worldcat.org/fast/fst01423772
|
| 700 |
1 |
|
|a Tsubura, Eirō,
|d 1925-
|0 http://id.loc.gov/authorities/names/n85286715
|1 http://viaf.org/viaf/109072435
|
| 700 |
1 |
|
|a Urushizaki, Ichirō.
|0 http://id.loc.gov/authorities/names/n83153037
|1 http://viaf.org/viaf/53066253
|
| 700 |
1 |
|
|a Aoki, Tadao.
|0 http://id.loc.gov/authorities/names/n85286716
|1 http://viaf.org/viaf/306158815
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a Hathi
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i 7b9befcf-9ad2-5057-95cc-9ae971e5e5a8
|s b996a053-5773-5b52-8e5e-7cacc5cc8420
|
| 928 |
|
|
|t Library of Congress classification
|a RC271.A35S9 1984
|l ASR
|c ASR-SciASR
|i 1894974
|
| 927 |
|
|
|t Library of Congress classification
|a RC271.A35S9 1984
|l ASR
|c ASR-SciASR
|e CRERAR
|b 48945077
|i 1770372
|
